When considering the class of treatment prescribed, only systemic antibiotics and systemic steroids showed a significant increased risk of discontinuation, while immunomodulatory drugs (apremilast) had a barely significant reduced risk of discontinuation (RR: 0.86; 95% CI: 0.74–1.01).
← all excerpts
Treatment Survival and Reasons for Discontinuation in Patients with Recalcitrant Folliculitis Decalvans.
1
—
—